Diagnostic impact of CSF biomarkers in a local hospital memory clinic.

Maartje I. Kester,Leo Boelaarts,Femke H. Bouwman,Raymond L.C. Vogels,Erwin R. Groot,Evert J. van Elk,Marinus A. Blankenstein,Wiesje M. van der Flier,Philip Scheltens

Diagnostic impact of CSF biomarkers in a local hospital memory clinic.

2010

Maartje I. Kester
Leo Boelaarts
Femke H. Bouwman
Raymond L.C. Vogels
Erwin R. Groot
Evert J. van Elk
Marinus A. Blankenstein
Wiesje M. van der Flier
Philip Scheltens

Background: CSF biomarkers amyloid-β 1–42 (Aβ42), total tau (tau) and tau phosphorylated at threonine 181 (ptau-181) are useful diagnostic markers for Alzheimer’s disease (AD). We e

Keywords:

Memory clinic
Biomarker (medicine)
Alzheimer's disease
Differential diagnosis
Psychology
Pathology
Disease
Cerebrospinal fluid
Cognitive disorder
Degenerative disease
Internal medicine
Central nervous system disease
Oncology
Psychiatry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations